District Court, D. New Jersey September 22, 2022, 2:21-cv-20452 (BERNSTEIN v. BRISTOL-MYERS SQUIBB CO.)
Also known as
United States · · · 22-09-2022
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NEW JERSEY
HOWARD BERNSTEIN, on behalf of
himself and all others similarly
situated,
Plaintiff,
v. Civ. No. 21-20452 (KM) (CLW)
BRISTOL-MYERS SQUIBB CO., et al., OPINION
Defendant.
KEVIN MCNULTY, U.S.D.J.:
Plaintiff Howard Bernstein, on behalf of himself and others similarly
situated, filed this putative class action against Defendant Bristol-Myers
Squibb Company (“BMS”) and several of its directors and officers (collectively,
“Defendants”) in New Jersey state court, alleging that the Form S-4 registration
statement BMS filed with the U.S. Securities and Exchange Commission
pertaining to certain Contingent Value Rights (the “Registration Statement”)
was false and misleading, in violation of the Securities Act of 1933, 15. U.S.C. §
77a et seq.
Now before the Court are Defendants’ motion to transfer venue, and
Plaintiff’s motion to remand the case to state court. For the reasons expressed
below, Plaintiff’s motion to remand is GRANTED, and Defendants’ motion to
transfer venue is DENIED.
BACKGROUND
On November 12, 2021, Plaintiff filed the complaint in this action in the
Superior Court of New Jersey, Law Division, Union County. (DE 1 Ex. 2.) The
complaint is related to BMS’s 2019 acquisition of Celgene Corporation, the
consummation of which included BMS issuing approximately 714.9 million
new shares of common stock and 714.9 Contingent Value Rights (“CVRs”) to
former holders of Celgene stock. (DE 1 Ex. 2 ¶ 6.) Plaintiff alleges that the
Registration Statement BMS filed in connection with the acquisition was false
and misleading, in violation of the Securities Act of 1933 (the “’33 Act”),
because it failed to disclose actions BMS was taking that would delay approval
by the Food and Drug Administration of a blockbuster cancer therapy Celgene
had been developing, thereby preventing a $6.4 billion payout promised to CVR
holders. (DE 1 Ex. 2 ¶ 6.
Read the full text
This document is published by courtlistener.com.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit